Biotech Values

[genisi]

This throws a monkey-wrench into the theory that a nucleotide-backbone is required for oral therapy.

I think that at least in the previous non responders (arm 3) where 6 patients had viral breakthroughs, nukes with their higher barrier to resistance will do better.